Sirolimus-based product as a next-generation therapeutic for the treatment/prevention of wet AMD and the treatment of diabetic macular edema.
There’s no risk. Start your trial today to see profiles of MacuSight plus 5589 other startups.
Start Free 7 Day Trial Now